Market Currents
Mylan (MYL +1.9%) gets a bump higher after the generic-drug maker raised its FY12 earnings...
-
Thursday, May 10, 2012, 2:24 PM ETMylan (MYL +1.9%) gets a bump higher after the generic-drug maker raised its FY12 earnings outlook earlier today. It now expects to earn between $2.45 - $2.55 per share. Street consensus is for an EPS of $2.42. The company also outlined plans to repurchase up to $500M in stock in a bid to increase shareholder value.
Other date
HEALTHCARE ETFs IN FOCUS
Latest Healthcare Articles
